Inventor · disambiguated record
Yu-Waye Chu
Also filed as: CHU YU-WAYE
3 granted patents·10 pending applications·11 citations·filing 2015–2025
67Inventor score
Top patents by PatentIndex Score
13 records- 0186US11000510B2Methods of using anti-CD79b immunoconjugatesGENENTECH INC·Filed 2019·Granted May 11, 2021·2 cites·49 claims
- 0285US12016842B2Methods of using anti-CD79b immunoconjugatesGENENTECH INC·Filed 2021·Granted Jun 25, 2024·1 cites·18 claims
- 0383US11466094B2Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodiesGENENTECH INC·Filed 2017·Granted Oct 11, 2022·8 cites·82 claims
- 0483US2025073212A1METHODS OF USING ANTI-CD79b IMMUNOCONJUGATESGENENTECH INC·Filed 2024·Application pending·0 cites
- 0581US2024376223A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 0679US2024132613A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodiesGENENTECH INC·Filed 2023·Application pending·0 cites
- 0776US2023242659A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodiesGENENTECH INC·Filed 2023·Application pending·0 cites
- 0871US2021346352A1METHODS OF USING ANTI-CD79b IMMUNOCONJUGATESGENENTECH INC·Filed 2021·Application pending·0 cites
- 0970US2025171552A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodiesGENENTECH INC·Filed 2025·Application pending·0 cites
- 1058US2024382523A1Off-the-shelf ipsc-derived car-nk cell as monotherapy and in combination with antibodyFATE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1157US2017304438A1METHODS OF USING ANTI-CD79b IMMUNOCONJUGATESGENENTECH INC·Filed 2017·Application pending·0 cites
- 1255US2024100092A1OFF-THE-SHELF iPSC-DERIVED NK CELL THERAPY FOR HEMATOLOGICAL CANCER TREATMENTFATE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1353US2016082120A1METHODS OF USING ANTI-CD79b IMMUNOCONJUGATESGENENTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yu-Waye Chu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →